Paper II
2025 March (Supplementary) (2010 Scheme)

Question

Amphotericin B.

Q73 marksShort Notes

Answer

Amphotericin B is a polyene antifungal, the broadest-spectrum systemic antifungal available.

MOA: amphotericin Bbinds ergosterol directly in the fungal cell membrane → forms pores that disrupt membrane integrity → leakage of intracellular contents → fungicidal. Its selectivity depends on ergosterol-versus-cholesterol binding preference, which is real but imperfect — residual affinity for cholesterol in human cell membranes, particularly renal tubular cells, is the direct mechanistic basis for its nephrotoxicity.

Uses: severe systemic/invasive fungal infections (invasive candidiasis, aspergillosis, cryptococcal meningitis), visceral leishmaniasis (particularly the liposomal formulation).

Adverse effects: nephrotoxicity (dose-limiting), infusion-related reactions (fever, chills, rigors — “shake and bake”), hypokalemia, hypomagnesemia, anemia. Liposomal formulations were developed specifically to reduce the off-target renal binding while preserving antifungal efficacy.

Other Years Asked


Revise MBBS
Preview